News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
NIH Awards Penn State CTSI $28.2M to Improve Rural Health
September 1, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival
August 31, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Two Popular Diabetes Drugs Outperformed Others in Large Clinical Trial
September 21, 2022 - NCATS News
- Compound Management
NIH-funded researchers complete first study comparing commonly used type 2 diabetes medications.
Mount Sinai, NCATS Scientists Uncover a Potential New Path Against Neurological Disease
September 8, 2022 - NCATS News
- Chemistry Technology
Researchers at the Icahn School of Medicine at Mount Sinai in New York and NCATS identified compounds that, when tested in patient cells and mice, reversed the effects of several neurodegenerative diseases called lysosomal storage disorders (LSDs). The findings could lead to treatments for other neurodegenerative diseases that have similar causes.
Tiny Antibodies May Provide New Tool to Fight COVID-19
August 30, 2022 - NCATS News
- COVID-19
An NIH-led team of scientists built a library of small antibodies, called synthetic nanobodies, to speed the search for therapeutics to combat new SARS-CoV-2 variants. They identified three nanobodies that seemed most effective in blocking infection.
Nationwide IRB Reliance Agreement Aimed at Speeding Research Reaches 1,000 Signatories
August 3, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- Our Impact on Research Operations
The Streamlined, Multisite, Accelerated Resources for Trials (SMART) Institutional Review Board (IRB) agreement has reached 1,000 participating sites, making it one of the largest medical research study reliance agreements in the United States.
COVID-19 Hospitalization May Increase Heart Failure Risk
July 15, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- National Clinical Cohort Collaborative (N3C)
- Our Impact on Big Data
A large, retrospective study using National COVID Cohort Collaborative (N3C) data revealed that people who had been hospitalized with COVID-19 were more likely to develop heart failure during their recovery than people who had been hospitalized without COVID-19.
Media Advisory: To Find Answers for People on Earth, NIH-Funded Tissue Chips Take Flight
July 13, 2022 - NCATS News
- Tissue Chip for Drug Screening
Two NIH-funded research teams will send tissue chips to the International Space Station National Laboratory (ISS-NL). The tissue chips will spend several weeks in orbit to collect information about why the aging process causes muscles to lose mass and strength and the immune system to work less effectively.